← Leaderboards
Biddanda C Ponnappa
Thomas Jefferson University
$1,771,486
Attributed
$1,771,486
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.6K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,771,486 · 3
By mechanism
R01$935,460 · 1
R21$836,026 · 2
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Joannes B Hoek$23,581,570
- Gyorgy Hajnoczky$24,552,568
- Scott A. Waldman$27,830,994
- Gyorgy Csordas$5,518,256
- Rajanikanth Vadigepalli$12,803,117
Others in their field
Top investigators on “Lipopolysaccharides”
- Bruce A Beutler · Ut Southwestern Medical Center$21,787,231
- Michael Stephen Trent · University Of Georgia$19,970,261
- Daniel E Kahne · Harvard University$19,426,946
- Robert O'Conner · Alion Science And Technology Corp$14,945,723
- Laura E. Nagy · Case Western Reserve University$14,567,506
- Stefanie N. Vogel · University Of Maryland Baltimore$13,942,871
Research focus
LipopolysaccharidesLiposomesRna InterferenceMessenger RnaMacrophageKupffer'S CellTumor Necrosis Factor AlphaAlcoholic Liver DamageDesignDiagnosticAftercareCytokineBaseBiodistributionAntibodiesClinicClinical ResearchChronicAnimal ModelAlcoholic HepatitisCell SurfaceCessation Of LifeCholangiocyteAffinity
Grant awards (7)
SiRNAs in the Treatment of Alcoholic Liver Disease$309,734
R01 · FY2010 · AA · contact PI
SiRNAs in the Treatment of Alcoholic Liver Disease$312,863
R01 · FY2009 · AA · contact PI
SiRNAs in the Treatment of Alcoholic Liver Disease$312,863
R01 · FY2008 · AA · contact PI
Targeting Kupffer Cells With Short-Interfering RNA$225,688
R21 · FY2005 · AA
Cell-type specific targting of curcumin$211,950
R21 · FY2005 · CA
Cell-type specific targeting of curcumin$211,950
R21 · FY2004 · CA
Targeting Kupffer Cells With Short-Interfering RNA$186,438
R21 · FY2004 · AA